KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income - MinorityNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Xylem (XYL) Revenue (2016 - 2025)

Xylem has reported Revenue over the past 16 years, most recently at $2.4 billion for Q4 2025.

  • Quarterly results put Revenue at $2.4 billion for Q4 2025, up 6.25% from a year ago — trailing twelve months through Dec 2025 was $9.0 billion (up 5.52% YoY), and the annual figure for FY2025 was $9.0 billion, up 5.52%.
  • Revenue for Q4 2025 was $2.4 billion at Xylem, up from $2.3 billion in the prior quarter.
  • Over the last five years, Revenue for XYL hit a ceiling of $2.4 billion in Q4 2025 and a floor of $1.3 billion in Q1 2021.
  • Median Revenue over the past 5 years was $1.9 billion (2023), compared with a mean of $1.8 billion.
  • Biggest five-year swings in Revenue: fell 3.64% in 2021 and later surged 50.43% in 2023.
  • Xylem's Revenue stood at $1.3 billion in 2021, then rose by 13.83% to $1.5 billion in 2022, then surged by 40.64% to $2.1 billion in 2023, then rose by 6.52% to $2.3 billion in 2024, then grew by 6.25% to $2.4 billion in 2025.
  • The last three reported values for Revenue were $2.4 billion (Q4 2025), $2.3 billion (Q3 2025), and $2.3 billion (Q2 2025) per Business Quant data.